6929 — OrbusNeich Medical group Share Price
0.000.00%
Last trade - 00:00- HK$3.20bn
- HK$1.26bn
- $153.87m
- 76
- 63
- 25
- 58
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 8.45 | ||
| PEG Ratio (f) | 1.23 | ||
| EPS Growth (f) | 7.4% | ||
| Dividend Yield (f) | 2.5% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.11 | ||
| Price to Tang. Book | 1.18 | ||
| Price to Free Cashflow | 26.3 | ||
| Price to Sales | 2.66 | ||
| EV to EBITDA | 3.72 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 10.66% | ||
| Return on Equity | 13.05% | ||
| Operating Margin | 25.96% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 96.34 | 88.47 | 116.46 | 136.82 | 153.87 | 177.76 | 206.51 | 12.42% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | -25.82 | n/a | n/a | +65.78 | +1.68 | +18.18 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
OrbusNeich Medical Group Holdings Ltd is an investment holding company principally engaged in the development, production and sales of medical equipment and machineries. The Company is engaged in the design, development, manufacture, distribution and sale of interventional medical devices for the treatment of coronary heart disease and peripheral vascular diseases. The Company's main products include percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) balloons. In addition, the Company's products also include semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, coronary stents for implantation, non-compliant balloons for post-dilatation and specialty catheters. The Company mainly conducts its businesses in domestic and overseas markets.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- July 22nd, 2021
- Public Since
- December 23rd, 2022
- No. of Employees
- 1,249
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 827,968,337
- Address
- New Territories
- Web
- https://orbusneich.com/
- Phone
- +852 null28022288
- Auditors
- PricewaterhouseCoopers
Upcoming Events for 6929
OrbusNeich Medical Group Holdings Ltd Annual Shareholders Meeting
Dividend For 6929.HK - 0.1000 HKD
Similar to 6929
Acotec Scientific Holdings
Stock Exchange of Hong Kong Limited
Beijing Airdoc Technology Co
Stock Exchange of Hong Kong Limited
AK Medical Holdings
Stock Exchange of Hong Kong Limited
AMCO United Holding
Stock Exchange of Hong Kong Limited
Angelalign Technology
Stock Exchange of Hong Kong Limited
FAQ
What is the OrbusNeich Medical group share price?
As of Today at 19:16 UTC, shares in OrbusNeich Medical group are trading at HK$3.86. This share price information is delayed by 15 minutes.
How has the OrbusNeich Medical group share price performed this year?
Shares in OrbusNeich Medical group last closed at HK$3.86 and the price had moved by -69.89% over the past 365 days. In terms of relative price strength the OrbusNeich Medical group share price has underperformed the FTSE Developed Asia Pacific Index by -70.12% over the past year.
What are the analyst and broker recommendations for OrbusNeich Medical group?
The overall consensus recommendation for OrbusNeich Medical group is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the OrbusNeich Medical group dividend yield?
The OrbusNeich Medical group dividend yield is 2.59% based on the trailing twelve month period.
Does OrbusNeich Medical group pay a dividend?
Last year, OrbusNeich Medical group paid a total dividend of $0.01, and it currently has a trailing dividend yield of 2.59%.Looking ahead, shares in OrbusNeich Medical group are due to go ex-dividend on 2024-06-11 and the next dividend pay date is 2024-06-28.
When does OrbusNeich Medical group next pay dividends?
OrbusNeich Medical group are due to go ex-dividend on 2024-06-11 and the next dividend pay date is 2024-06-28. The historic dividend yield on OrbusNeich Medical group shares is currently 2.59%.
How do I buy OrbusNeich Medical group shares?
To buy shares in OrbusNeich Medical group you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of OrbusNeich Medical group?
As of the previous close price of HK$3.86, shares in OrbusNeich Medical group had a market capitalisation of HK$3.20bn.
Where are OrbusNeich Medical group shares listed?
Here are the trading details for OrbusNeich Medical group:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 6929
What kind of share is OrbusNeich Medical group?
Based on an overall assessment of its quality, value and momentum OrbusNeich Medical group is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a OrbusNeich Medical group share price forecast for 2024?
The analyst consensus target price for shares in OrbusNeich Medical group is HK$6.88. That is 78.35% above the last closing price of HK$3.86.
Analysts covering OrbusNeich Medical group currently have a consensus Earnings Per Share (EPS) forecast of $0.06 for the next financial year.
What is the trend in the OrbusNeich Medical group share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like OrbusNeich Medical group. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -54.19%.
As of the last closing price of HK$3.86, shares in OrbusNeich Medical group were trading -41.35% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the OrbusNeich Medical group PE Ratio?
The OrbusNeich Medical group PE ratio based on its reported earnings over the past 12 months is 8.45. The shares last closed at HK$3.86.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of OrbusNeich Medical group?
We do not have data on OrbusNeich Medical group's directors